EDIFY

Reagents for scientific and research use, namely, for use in the manufacturing process of cell therapy platforms to train T-cells to target multiple tumor associated antigens; biochemical preparations in the form of biochemical platforms for scientific purposes, namely, for the manufacturing of cell therapy that trains T-cells to target multiple tumor associated antigens

Pharmaceutical preparations for the treatment of cancer that educate immune cells, without viral, non-viral or other genetic modifications, to manufacture multi-tumor associated antigen T-cells

Manufacturing of cell therapy platforms for others that trains T-cells to target multiple tumor associated antigens

Platform as a service (PAAS) featuring biological computer software platforms for developing drug products to improve ability to target tumor cells; Platform as a service (PAAS) featuring biological computer software platforms for research and development of pharmaceuticals for use with cell therapy to manufacture tumor-targeted T-cell products and target tumor-specific antigens without genetic modification